OMNI Health Media is a leading online provider of Daily Health News. OMNI’s Precision Medicine News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
Opdivo (nivolumab) Improves Survival in Patients with Advanced Gastric Cancer

February 6, 2017

Opdivo (nivolumab) Improves Survival in Patients with Advanced Gastric Cancer

By Anonymous User anonymous_user_10987

At the 2017 Gastrointestinal Cancers Symposium in San Francisco researchers presented new trial results demonstrating that Opdivo (nivolumab) significantly reduced the risk of death by 37% in patients with previously treated advanced gastric cancer refractory to or intolerant of standard therapy, a condition without current standard-of-care treatments. About Gastric Cancer Gastric cancer refers to cancer of the […]

View full entry

Tags: Gastric Cancer, immunotherapy, News Tips and Features, News Tips and Features Other, nivolumab, Opdivo, precision medicine

View more articles like this
More news and in-depth Gastric Cancer information